Psychemedics (PMD) Competitors $2.67 -0.05 (-1.84%) (As of 12/12/2024) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends PMD vs. ENZ, CCM, TOI, MRAI, BRTX, OPGN, KDLY, OTRK, MGRX, and VSEEShould you be buying Psychemedics stock or one of its competitors? The main competitors of Psychemedics include Enzo Biochem (ENZ), Concord Medical Services (CCM), Oncology Institute (TOI), Marpai (MRAI), BioRestorative Therapies (BRTX), OpGen (OPGN), Kindly MD (KDLY), Ontrak (OTRK), Mangoceuticals (MGRX), and Vsee Health (VSEE). These companies are all part of the "healthcare" industry. Psychemedics vs. Enzo Biochem Concord Medical Services Oncology Institute Marpai BioRestorative Therapies OpGen Kindly MD Ontrak Mangoceuticals Vsee Health Psychemedics (NASDAQ:PMD) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, community ranking, media sentiment and institutional ownership. Do insiders and institutionals hold more shares of PMD or ENZ? 32.1% of Psychemedics shares are owned by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are owned by institutional investors. 14.0% of Psychemedics shares are owned by insiders. Comparatively, 11.4% of Enzo Biochem shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is PMD or ENZ more profitable? Psychemedics has a net margin of -14.59% compared to Enzo Biochem's net margin of -81.73%. Enzo Biochem's return on equity of -11.84% beat Psychemedics' return on equity.Company Net Margins Return on Equity Return on Assets Psychemedics-14.59% -49.05% -27.26% Enzo Biochem -81.73%-11.84%-8.31% Which has better earnings & valuation, PMD or ENZ? Psychemedics has higher earnings, but lower revenue than Enzo Biochem. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPsychemedics$22.10M0.71-$4.15M-$0.51-5.24Enzo Biochem$30.31M1.31-$26.08MN/AN/A Which has more risk & volatility, PMD or ENZ? Psychemedics has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500. Does the media refer more to PMD or ENZ? In the previous week, Enzo Biochem had 4 more articles in the media than Psychemedics. MarketBeat recorded 6 mentions for Enzo Biochem and 2 mentions for Psychemedics. Psychemedics' average media sentiment score of 1.89 beat Enzo Biochem's score of -0.35 indicating that Psychemedics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Psychemedics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Enzo Biochem 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Does the MarketBeat Community prefer PMD or ENZ? Enzo Biochem received 70 more outperform votes than Psychemedics when rated by MarketBeat users. However, 74.35% of users gave Psychemedics an outperform vote while only 54.78% of users gave Enzo Biochem an outperform vote. CompanyUnderperformOutperformPsychemedicsOutperform Votes14274.35% Underperform Votes4925.65% Enzo BiochemOutperform Votes21254.78% Underperform Votes17545.22% SummaryEnzo Biochem beats Psychemedics on 8 of the 13 factors compared between the two stocks. Ad Porter & CompanyFirst JFK… next Elon?Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. Get Psychemedics News Delivered to You Automatically Sign up to receive the latest news and ratings for PMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PMD vs. The Competition Export to ExcelMetricPsychemedicsMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.73M$2.93B$5.14B$9.08BDividend YieldN/A15.63%5.09%4.23%P/E Ratio-5.2416.0289.9717.18Price / Sales0.71284.461,116.21116.99Price / CashN/A472.1142.8937.86Price / Book2.325.194.784.78Net Income-$4.15M-$32.86M$120.23M$225.60M7 Day PerformanceN/A-3.01%-1.92%-1.23%1 Month Performance14.10%2.96%11.49%3.36%1 Year Performance-6.97%12.37%30.57%16.60% Psychemedics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PMDPsychemedics1.3983 of 5 stars$2.67-1.8%N/A-5.3%$15.73M$22.10M-5.24140Insider TradeGap DownHigh Trading VolumeENZEnzo Biochem0.7773 of 5 stars$1.01-1.0%N/A-46.7%$52.77M$31.91M0.00520Earnings ReportAnalyst ForecastCCMConcord Medical Services0.3768 of 5 stars$4.99+0.8%N/A-58.8%$21.67M$471.70M0.00970Analyst ForecastNews CoverageGap DownTOIOncology Institute2.5251 of 5 stars$0.21-5.8%$2.50+1,090.5%-88.1%$15.87M$378.93M-0.29660MRAIMarpaiN/A$1.11-11.2%$6.00+440.5%-47.7%$15.25M$34.87M-0.42150Gap DownBRTXBioRestorative Therapies3.455 of 5 stars$1.44-0.9%$18.00+1,152.6%-11.4%$9.94M$150,000.00-0.917OPGNOpGenN/A$1.07-3.6%N/A-82.8%$8.95M$3.42M0.00100Analyst ForecastNews CoverageGap DownKDLYKindly MDN/A$1.20-7.8%N/AN/A$7.16M$2.88M0.00N/AGap DownOTRKOntrak2.6135 of 5 stars$1.60-2.4%$45.00+2,712.5%-76.2%$6.75M$11.24M-0.15250Positive NewsMGRXMangoceuticals1.1789 of 5 stars$2.53-3.1%N/A-96.2%$6.29M$755,000.00-0.453News CoveragePositive NewsGap DownVSEEVsee HealthN/A$1.39-6.7%N/AN/A$5.01M$6.38M0.00N/ANews Coverage Related Companies and Tools Related Companies ENZ Competitors CCM Competitors TOI Competitors MRAI Competitors BRTX Competitors OPGN Competitors KDLY Competitors OTRK Competitors MGRX Competitors VSEE Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PMD) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psychemedics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psychemedics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PMD Stock Alerts